Why Patients Choose Wegovy to Mounjaro Conversion Charts
The wegovy to mounjaro conversion chart represents a growing need as patients explore their GLP-1 medication options. Wegovy (semaglutide) is a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) works as a dual GIP and GLP-1 receptor agonist, creating different mechanisms of action. Patients often switch due to side effect profiles, storage requirements, cost considerations, or availability issues. The conversion isn't direct equivalency but rather a carefully managed transition under medical supervision.
Understanding the wegovy to mounjaro conversion chart requires recognising that both are prescription-only medicines requiring clinical assessment. Wegovy follows a structured dose escalation from 0.25mg through to 2.4mg maintenance, whilst Mounjaro escalates from 2.5mg to 15mg maximum. Your prescriber will determine the most appropriate starting dose when switching, considering your current response, tolerance, and individual circumstances. EverydayMeds stocks both medications through our GPhC-registered pharmacy (#9012878), ensuring continuity of care during your transition.
Wegovy to Mounjaro Conversion Chart: Pricing Comparison
When examining the wegovy to mounjaro conversion chart from a cost perspective, Wegovy often presents attractive savings opportunities. Our single pen prices start at £79.99 for 0.25mg (with code FIRST40), £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. These represent the final prices after discount codes are applied at checkout. New customers use code FIRST40, whilst returning customers apply code DOSE25 for ongoing savings.
For patients requiring multiple pens, our bundles provide convenient supply options. The Intro Duo (0.25mg & 0.5mg) costs £169.99, perfect for starting your switch. The Progress Duo (0.5mg & 1mg) at £189.99 supports continued escalation. Our Consistency bundles offer two identical doses: Consistency 1mg (×2) for £209.99 or Consistency 2.4mg (×2) for £419.99. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment during your established phase.
Clinical Evidence Supporting Wegovy Conversion Charts
The wegovy to mounjaro conversion chart gains credibility from robust clinical evidence. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved significant weight management outcomes. STEP 1 demonstrated approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events with Wegovy treatment.
These clinical results support why patients reference wegovy to mounjaro conversion charts when making treatment decisions. However, individual responses vary, and switching medications should always occur under medical supervision. Both medications require prescription-only access and regular monitoring to ensure optimal outcomes and safety throughout the transition period.
How Wegovy Works in Your Conversion Chart Decision
Understanding Wegovy's mechanism helps inform your wegovy to mounjaro conversion chart considerations. Semaglutide acts as a GLP-1 receptor agonist, mimicking your body's natural incretin hormones that regulate blood sugar and appetite. It slows gastric emptying, promoting feelings of fullness after smaller meals and potentially reducing food cravings by working on brain appetite centres. The once-weekly FlexTouch pen injection provides consistent medication levels throughout the week. This differs from Mounjaro's dual GIP and GLP-1 action, offering an alternative approach to weight management alongside a reduced-calorie diet and increased physical activity.
Streamlined Ordering Process for Your Wegovy Conversion
Accessing Wegovy through your conversion chart decision involves our straightforward three-step process. Complete our 3-minute online clinical assessment, providing medical history and current medication details including your Mounjaro experience. Our prescribers review applications within standard 3 working days (or 24 hours with express service), ensuring safe transition protocols are followed. Once approved, next-day delivery arrives via temperature-controlled cold-chain transport, maintaining medication integrity from our pharmacy to your door. This seamless process ensures no treatment gaps when switching from Mounjaro to Wegovy.
Storage Advantages in Your Wegovy to Mounjaro Conversion Chart
Storage convenience represents a key factor in many wegovy to mounjaro conversion charts. Wegovy maintains potency for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. Standard storage requires refrigeration at 2-8°C before first use. The FlexTouch pen design offers user-friendly injection with dose escalation progressing systematically: 0.25mg for weeks 1-4, 0.5mg for weeks 5-8, 1mg for weeks 9-12, 1.7mg for weeks 13-16, and 2.4mg for maintenance from week 17 onwards. This structured approach cannot skip doses, ensuring optimal tolerance and efficacy during your conversion period.
Personalised Wegovy to Mounjaro Conversion Chart Strategy
Your individual wegovy to mounjaro conversion chart strategy depends on multiple factors including your current Mounjaro dose, treatment duration, side effect experience, and response patterns. Patients switching from higher Mounjaro doses may start Wegovy at 0.25mg following standard escalation protocols, rather than attempting dose equivalency. The transition period typically involves stopping Mounjaro and beginning Wegovy's structured dose escalation under medical guidance.
Some patients find the different mechanism of action beneficial - switching from dual GIP/GLP-1 activation to pure GLP-1 receptor agonism may improve tolerance whilst maintaining efficacy. Others appreciate Wegovy's established clinical profile and longer market presence. Your prescriber will create a personalised conversion chart timeline based on your specific circumstances, ensuring safe and effective medication transition.
Complete Your Wegovy to Mounjaro Conversion Chart Journey
Ready to implement your wegovy to mounjaro conversion chart plan? Start with our clinical assessment at https://everydaymeds.co.uk/collections/weight-loss where our medical team will evaluate your switching suitability. New customers save with code FIRST40, whilst returning customers use DOSE25 for continued value. Our GPhC-registered pharmacy ensures professional standards throughout your conversion journey. Both Wegovy and Mounjaro remain available through EverydayMeds, providing flexibility should your needs change. Contact our clinical team for personalised guidance on your weight management transition, ensuring optimal outcomes with professional medical oversight throughout the switching process.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026